Literature DB >> 6641663

Cell-mediated cytotoxicity expressed by lymphoid cells from rats with asbestos-induced peritoneal mesothelioma towards rat fetal cell.

R H Stevens, D A Cole, H F Cheng, J A Hodge, L A Will.   

Abstract

Cell-mediated immunity (CMI) directed towards rat fetal cells was evaluated in Fischer F344 young inbred male rats having asbestos-induced peritoneal mesothelioma. The tumors were induced by exposure to Canadian chrysotile B fibers and the CMI delineated by the injury and destruction brought about to 6- to 10-day-old primary fetal cell cultures by the so-called educated peripheral blood lymphoid-cells (PBLC) obtained from the cancer-bearing rats. A significant cytotoxicity was found to be expressed by the PBLCs, suggesting that during the development of mesothelioma, a cellular retrodifferentiation occurs, thereby educating the effectors to recognize a common determinant existing in both the tumor and fetal cells. Educated PBLCs were produced from rats having endodermal tissue cancers (adenocarcinomas of the small bowel, colon and pancreas) and were found to also be cytotoxic to the fetal cultures, yet no injury was apparently inflicted upon cultured mesothelioma target cells by these effectors. These results suggested that the tumor education was specific and that probably a unique and different fetal component was being recognized by the effector cells obtained from the rats with lesions arising either in the mesodermal or endodermal tissue. Further support for this concept was the failure of an antibody, specific to an oncofetal protein existing in endodermal lesions, to apparently recognize any common oncogenic proteins in the mesothelioma. Preliminary studies have also been accomplished which suggests the existence of natural killing immune responses existing to the mesothelioma target cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6641663      PMCID: PMC1569267          DOI: 10.1289/ehp.835191

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  22 in total

1.  Carcinoembryonic antigen: clinical application.

Authors:  V L Go
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

2.  Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats.

Authors:  B S Reddy; T Narisawa; P Wright; D Vukusich; J H Weisburger; E L Wynder
Journal:  Cancer Res       Date:  1975-02       Impact factor: 12.701

3.  An animal model for the study of small-bowel tumors.

Authors:  K L Coop; J G Sharp; J W Osborne; G R Zimmerman
Journal:  Cancer Res       Date:  1974-06       Impact factor: 12.701

4.  Separation of blood leucocytes, granulocytes and lymphocytes.

Authors:  A Boyum
Journal:  Tissue Antigens       Date:  1974

5.  Proceedings: Escape from immune destruction by the host through shedding of surface antigens: is this a characteristic shared by malignant and embryonic cells?

Authors:  P Alexander
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

6.  Oncofetal protein accompanying irradiation-induced small-bowel adenocarcinoma in the rat.

Authors:  R H Stevens; C W England; J W Osborne; H F Cheng; H B Richerson
Journal:  J Natl Cancer Inst       Date:  1975-10       Impact factor: 13.506

7.  Assessment of cell-mediated immunity to malignant mesothelioma by microcytotoxicity tests.

Authors:  M J Embleton; J C Wagner; M M Wagner; J S Jones; G Sheers; P D Oldham; R W Baldwin
Journal:  Int J Cancer       Date:  1976-05-15       Impact factor: 7.396

8.  Chemical-and X-ray-induced antitumor cell-mediated immunity to rat fetal cells.

Authors:  R H Stevens; D A Cole; H F Cheng
Journal:  Oncodev Biol Med       Date:  1982

9.  DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.

Authors:  P GOLD; S O FREEDMAN
Journal:  J Exp Med       Date:  1965-03-01       Impact factor: 14.307

10.  Specific carcinoembryonic antigens of the human digestive system.

Authors:  P Gold; S O Freedman
Journal:  J Exp Med       Date:  1965-09-01       Impact factor: 14.307

View more
  1 in total

Review 1.  Nonpulmonary outcomes of asbestos exposure.

Authors:  Melisa Bunderson-Schelvan; Jean C Pfau; Robert Crouch; Andrij Holian
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.